Abstract

ObjectiveTo investigate the risk factors for neurogenic pulmonary edema (NPE) in patients with severe hand, foot, and mouth disease (HFMD) and to provide evidence for the prevention and treatment of NPE. MethodsSeveral databases were searched (from inception to 2017) to identify case–control studies on risk factors for NPE among patients with severe HFMD. Data were analyzed via meta-analysis. The combined odds ratio (OR) and 95% confidence interval (CI) were calculated using fixed-effects and random-effects models, and a sensitivity analysis and evaluation of publication bias was also performed. ResultsA total of 14 studies involving 557 cases (severe HFMD with NPE) and 1450 controls (severe HFMD) were included. Results for the categorical variables were as follows: hyperglycemia (OR 10.25, 95% CI 4.82–21.76), tachycardia (OR 6.21, 95% CI 3.02–12.75), hypertension (OR 3.79, 95% CI 2.90–4.95), respiratory rhythm abnormality (OR 7.86, 95% CI 2.46–25.12), drowsiness (OR 8.11, 95% CI 4.26–15.44), vomiting (OR 8.96, 95% CI 3.83–20.96), limb tremors (OR 8.96, 95% CI 3.83–20.96), atypical rash (OR 4.27, 95% CI 2.83–6.45). No significant publication bias was found for the different factors. ConclusionsDrowsiness ranks first among risk factors for NPE in children with severe HFMD, followed by vomiting, tachycardia, hypertension, breathing rhythm changes, limb tremors, atypical rash, and hyperglycemia.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.